Patients with malignant disease often have an immune paresis due to the disease itself or to treatment with cytotoxic drugs, corticosteroids or radiotherapy. They are consequently prone to opportunistic infections which may be particularly severe or occur at unusual sites. Toxoplasma encephalitis complicating malignant disease is an example of this phenomenon, and a case is described in a patient suffering from Hodgkin's disease and resident in Chichester, Sussex. A search of the literature has not revealed any previous cases occurring in the United Kingdom.
Case Report A woman aged 44 years presented at another hospital in 1961 with generalized pruritus and was found to have bilateral cervical, axillary, and mediastinal lymphadenopathy. Biopsy of a cervical node was performed and histology showed sinus catarrh only. In spite of the negative histology it was decided to treat her as though she had Hodgkin's disease, and she received two doses of intravenous mustine followed by megavoltage radiotherapy to the mediastinum, neck, and axilla.
In 1966, a recurrent lymph node was excised from the right axilla and showed the histological features of Hodgkin's disease of mixed cellularity (fig 1) Toxoplasma encephalitis complicating Hodgkin's disease At necropsy several fairly well circumscribed, rounded lesions (10-40 mm in diameter) were found scattered indiscriminately in the white matter, cortex, and basal ganglia of both cerebral hemispheres. The lesions consisted of pale yellowish, friable, crumbling tissue. Microscopy revealed the presence of numerous Toxoplasma cysts and free trophozoites in and around necrotic areas in the cerebral hemispheres (fig 2) . There was no evidence of infection with Toxoplasma gondii outside the central nervous system nor of residual Hodgkin's disease in any part of the body.
Comment
A benign lymphadenopathy is the most common manifestation of infection with T. gondii in patients with normal immune function (Feldman, 1968) .
Involvement of the brain is extremel'y uncommon in the adult, although it does occur in the foetus. A necrotizing Toxoplasma encephalitis can be seen, however, in patients with malignant diseases; this was first described by Arias Stella (see Frenkel, 1956-7) . Vietzke et al (1968) and Carey et al (1973) reported further cases and reviewed the literature. The light and electron microscopic appearances were studied by Ghatak et al (1970) . Similar cases have occurred in patients receiving immunosuppressive therapy for non-malignant conditions (Reynolds et al, 1966; Cohen, 1970; Dubin et al, 1971) .
Infection with T. gondii is common in England; for instance, more than 40 % of women over 40 years of age living in South London have Toxoplasma dye test titres positive at 1/16 or more (Fleck, 1969) . It is therefore surprising that Toxoplasma encephalitis has not been reported as a complication of malignancy in the United Kingdom. While this is an uncommon condition, it is important to make the diagnosis because treatment with sulphadiazine and pyrimethamine may be successful (Vietzke et al, 1968) . Folinic acid can be used to prevent the myelosuppressive effect of pyrimethamine without impairing its therapeutic action (see TenPas and Abraham (1965) for review). Suspicion may be aroused by the clinical picture and a rising Toxoplasma dye test titre. The diagnosis has been confirmed in some cases by biopsy of the cerebral lesions and the discovery of the organisms on microscopy or after inoculation of biopsy material into mice (Vietzke et al, 1968) .
It was not possible to obtain the original lymph node biopsied in 1961 for review. It is interesting to speculate whether the sinus catarrh reported at that time was due to Toxoplasma lymphadenitis and whether the fatal encephalitis was caused by Toxoplasmas which had gained access to the body at that time and lain dormant until the development of a severe immune paresis.
There had been prolonged immune suppression due to Hodgkin's disease, cytotoxic drugs, corticosteroids, and radiotherapy in the patient described here. It is becoming increasingly common to see cases that are similar in this respect now that patients with malignant disease may live for long periods. More opportunistic infections with that ubiquitous organism, T. gondii, may therefore be seen in the United Kingdom.
